Aggregation of Microtubule Binding Repeats of Tau Protein is Promoted by Cu2

Soha Ahmadi1,2, Shaolong Zhu3,4, Renu Sharma1

  • 1Department of Physical and Environmental Science, University of Toronto Scarborough, 1265 Military Trail, Toronto, Ontario M1C 1A4, Canada.

ACS Omega
|April 20, 2019
PubMed

Insights

Copper (Cu2+) interaction with tau protein's microtubule binding repeats drives aggregation and reactive oxygen species (ROS) formation, key in Alzheimer's disease. Antioxidants do not prevent this copper-induced damage.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Alzheimer's disease pathogenesis involves tau aggregation and reactive oxygen species (ROS).
  • Microtubule (MT) binding repeats of tau protein are implicated in tau aggregation.

Purpose of the Study:

  • To investigate the role of Cu2+ interaction with tau's MT binding repeats in aggregation and ROS formation.
  • To elucidate the molecular mechanisms underlying copper-induced tau aggregation.

Main Methods:

  • Electrospray ionization mass spectrometry (ESI-MS) and Nuclear Magnetic Resonance (NMR) experiments.
  • Analysis of copper interaction with full-length MT binding repeats (R1-R4).
  • Assessment of antioxidant effects (ascorbate, glutathione) on copper-induced aggregation.

Main Results:

  • Cu2+ binding to R1-R4 tau repeats induces aggregation via Cys-based redox chemistry.
  • Disulfide-bridge dimerization of R2 and R3 occurs, leading to fibrillar structures.
  • Copper-bound MT repeats exhibit increased redox activity, generating ROS and causing cellular damage.
  • Ascorbate and glutathione failed to prevent Cu2+-induced R2/R3 aggregation.

Conclusions:

  • Copper interaction with tau MT binding repeats is a critical driver of tau aggregation and ROS production in Alzheimer's disease.
  • The findings reveal a novel molecular mechanism for tau aggregation and suggest the MT binding domain as a therapeutic target.

Related Concept Videos

Microtubules01:35

Microtubules

There are three types of cytoskeletal structures in eukaryotic cells—microfilaments, intermediate filaments, and microtubules. With a diameter of about 25 nm, microtubules are the thickest of these fibers. Microtubules carry out a variety of functions that include cell structure and support, transport of organelles, cell motility (movement), and the separation of chromosomes during cell division.
98.4K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
5.8K
Microtubule Associated Motor Proteins01:32

Microtubule Associated Motor Proteins

Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular...
10.5K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
536
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K